News

NKI Researchers Remain Highly Cited

Drs. F. Xavier Castellanos and Michael P. Milham

As they did last year, two NKI investigators appear on the 2018 Clarivate Analytics list of Highly Cited Researchers. F. Xavier Castellanos, MD, and Michael Milham, MD, PhD, are both recognized for their contributions in the field of Neuroscience & Behavior. Designation as a Highly Cited Researcher indicates authorship of multiple papers ranking in the top 1% by NKI Researchers Remain Highly Cited

Investigators Receive Funding to Probe Genetic Protection in Alzheimer’s

Efrat Levy, PhD, Paul Mathews, PhD (Center for Dementia Research), and Donald Wilson, PhD (Emotional Brain Institute) are Co-Principal Investigators on a large RF1 NIA grant titled “Neuronal protective apolipoprotein E2-mediated endocytic and exocytic pathways”. This application was in response to a request for applications from the NIA designed to fill in the significant gap in the Investigators Receive Funding to Probe Genetic Protection in Alzheimer’s

NKI Faculty Publish Frequently in Top-Tier Journals

Recent papers by NKI authors (highlighted) appearing in The American Journal of Psychiatry and JAMA Psychiatry. These include original investigations, reviews, and editorial pieces. Goff DC. Optimizing the Pharmacologic Treatment of Individuals With First-Episode Psychosis. Am J Psychiatry. 2018 Feb 1;175(2):101-102. Castellanos FX, Elmaghrabi SE. On the Road to Physiological Models of Brain Function in NKI Faculty Publish Frequently in Top-Tier Journals

NKI Researchers Are Consistently Among the Most Highly Cited

Two NKI investigators appear on the 2017 Clarivate Analytics list of Highly Cited Researchers. F. Xavier Castellanos, MD, and Michael Milham, MD, PhD, are both recognized for their contributions in the field of Neuroscience & Behavior. The selection criteria for this year’s list included authoring a high number of papers between 2005-2015 that rank in NKI Researchers Are Consistently Among the Most Highly Cited

NKI Scientists Receive Major Federal Grants for Alzheimer’s Research

On September 12, New York State Senator David Carlucci visited NKI and toured the Center for Dementia Research (CDR). During the Senator’s visit, NKI announced the awarding of several major federal research grants to CDR investigators, including a prestigious NIH Program Project Grant awarded to the CDR’s Director, Ralph Nixon, PhD, MD. Dr. Nixon commented, NKI Scientists Receive Major Federal Grants for Alzheimer’s Research

Nixon Lab Findings Announced at the Alzheimer’s Association International Conference

New findings from the laboratory of Center for Dementia Research Director Dr. Ralph Nixon (in collaboration with EIP Pharma, LLC) were announced at the Alzheimer’s Association International Conference held recently in London. The investigators found that the EIP licensed investigational drug neflamapimod reversed a critical Alzheimer’s-related physiologic defect in human patient cells cultured from individuals with Nixon Lab Findings Announced at the Alzheimer’s Association International Conference

OMH Clinical Laboratories Receive Accreditation from College of American Pathologists

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the OMH Clinical Laboratories located at the Nathan Kline Institute, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. The Laboratories Director, Timothy P. Hilbert, MD, PhD, JD, was advised of this national recognition and congratulated for OMH Clinical Laboratories Receive Accreditation from College of American Pathologists